hemophilia

Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A
Thu, 01/5/12 - 12:35 pm
Baxter
clinical trials
hemophilia
Dividend Stock Leader Novo Nordisk Keeps Innovating
Investor's Business Daily
Wed, 12/7/11 - 10:15 pm
hemophilia
Novo Nordisk
diabetes
dividends
Baxter Launches Fresh Initiative
Thu, 04/14/11 - 09:26 pm
Baxter International
hemophilia
Sangamo BioSciences to raise $51M in stock offering Read more: Sangamo BioSciences to raise $51M in stock offering | San Francisco Business Times
bizjournals.com
Sat, 04/9/11 - 10:53 am
Sangamo BioSciences
diabetic neuropathy
DPP HIV
hemophilia
brain cancer
Baxter Announces Acquisition of All Hemophilia-Related Assets of Archemix and an Exclusive License of Its Anti-TFPI Aptamer Technology
Fri, 11/19/10 - 03:00 pm
Baxter International
Archemix
hemophilia
Anti-TFPI Aptamer Technology
Baxter Creates New Medical Products Business and Announces Key Leadership Changes
Wed, 10/13/10 - 08:41 am
Baxter International
hemophilia
immune disorders
infectious diseases
kidney disease
trauma
Biogen says hemophilia drug meets safety goal
Yahoo/AP
Mon, 07/12/10 - 10:52 am
Biogen Idec
hemophilia
Biovitrum
Biogen and partner will advance hemophilia drug
Yahoo/AP
Fri, 07/9/10 - 11:40 am
Biogen Idec
hemophilia
Biovitrum
Biogen gets manufacturing rights for hemophilia therapy
Reuters
Thu, 02/18/10 - 10:59 am
Biogen Idec
hemophilia
Ipsen Buys Inspiration Stake in Hemophilia Alliance
Bloomberg
Thu, 01/21/10 - 07:47 am
hemophilia
Ipsen
Inspiration
M&A
Baxter loses Medicare hemophilia drug price suit
Yahoo/AP
Fri, 08/14/09 - 04:07 pm
Baxter International
hemophilia
Medicare
Advate
Baxter Beats Profit Estimates on Hemophilia, Antibody Sales
Bloomberg
Thu, 07/16/09 - 09:15 am
Baxter International
earnings
hemophilia

Pages